MedPath

Intra-articular Betamethasone and the Hypothalamic-pituitary-adrenal Axis

Completed
Conditions
Adrenal Suppression
Registration Number
NCT01799408
Lead Sponsor
The Nazareth Hospital, Israel
Brief Summary

To evaluate the effect of intra-articular corticosteroid injection (IACI) of depot preparation of betamethasone on the hypothalamic-pituitary-adrenal (HPA) axis, in patients with osteoarthritis of the knee

Detailed Description

Consecutive patients attending the rheumatology or orthopedic clinic with osteoarthritic knee pain, not responding satisfactorily to medical or physical therapy were allocated to group-1 after consent and given IACI of 6 mg of betamethasone acetate/betamethasone sodium phosphate. Following completion of this part, consecutive age- and sex-matched patients were allocated to group-2 and given intra-articular injection of 60 mg of sodium hyaluronate. Just prior to the knee injection and 1, 2, 3, 4 and 8 weeks later, patients had 1 µg adrenocorticotropin hormone (ACTH) stimulation test. Secondary adrenal insufficiency (SAI) was defined as levels of less than 18 ng/ml or a rise of \< than 7 ng/ml of serum cortisol, 30 minutes following the ACTH stimulation test.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Osteoarthritis of the knee
Exclusion Criteria
  • Had steroids in the last 3 months. Allergic to steroids

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adrenal Suppression2 months

Adrenal gland suupresion and inability to adequately secrete cortisol in response to stress

Secondary Outcome Measures
NameTimeMethod
favorable clinical response2 months
Favorable clinical response2 months following the steroid injection

Improvement of knee pain by more than 30 points according to visual analogue scale

© Copyright 2025. All Rights Reserved by MedPath